Bone Biologics Corporatio... (BBLG)
NASDAQ: BBLG
· Real-Time Price · USD
0.82
-0.02 (-2.38%)
At close: May 23, 2025, 3:58 PM
0.82
0.00%
After-hours: May 23, 2025, 04:00 PM EDT
-2.38% (1D)
| Bid | 0.79 |
| Market Cap | 2.68M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.48M |
| EPS (ttm) | -3.84 |
| PE Ratio (ttm) | -0.21 |
| Forward PE | -0.41 |
| Analyst | n/a |
| Ask | 0.88 |
| Volume | 48,756 |
| Avg. Volume (20D) | 161,334 |
| Open | 0.82 |
| Previous Close | 0.84 |
| Day's Range | 0.80 - 0.84 |
| 52-Week Range | 0.57 - 4.25 |
| Beta | 1.17 |
About BBLG
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BBLG
Website n/a
9 months ago
+0%
Bone Biologics shares are trading lower after the ...
Unlock content with
Pro Subscription
11 months ago
Bone Biologics shares are trading lower. The company announced that the first two patients have been treated in the multicenter, prospective, randomized pilot clinical study of the Company's NB1 bone graft device.
9 months ago · businesswire.com
Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross ProceedsBURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announce...
